Abstract
The expanded polytetrafluoroethylene (ePTFE) heart valve can serve as a viable option for prosthetic aortic valve. In this study, an ePTFE bi-leaflet valve design for aortic valve replacement (AVR) is presented, and the performance of the proposed valve was assessed numerically and experimentally. The valve was designed using CAE software. The dynamic behavior of the newly designed bi-leaflet valve under time-varying physiological pressure loading was first investigated by using commercial finite element code. Then, in-vitro tests were performed to validate the simulation and to assess the hemodynamic performance of the proposed design. A tri-leaflet ePTFE valve was tested in-vitro under the same conditions as a reference. The maximum leaflet coaptation area of the bi-leaflet valve during diastole was 216.3 mm2. When fully closed, no leakage gap was observed and the free edges of the molded valve formed S-shaped lines. The maximum Von Mises stress during a full cardiac cycle was 4.20 MPa. The dynamic performance of the bi-leaflet valve was validated by the in-vitro test under physiological aortic pressure pulse. The effective orifice area (EOA), mean pressure gradient, regurgitant volume, leakage volume and energy loss of the proposed valve were 3.14 cm2, 8.74 mmHg, 5.93 ml/beat, 1.55 ml/beat and 98.99 mJ, respectively. This study reports a novel bi-leaflet valve design for AVR. The performance of the proposed valve was numerically and experimentally assessed. Compared with the reference valve, the proposed design exhibited better structural and hemodynamic performances, which improved valve competency. Moreover, the performance of the bi-leaflet design is comparable to commercialized valves available on the market. The results of the present study provide a viable option for the future clinical applications.
Highlights
Congenital birth defects such as aortic incompetence may lead to aortic failure
Because of the encouraging mid- and long-term results in treating aortic stenosis or aortic regurgitation, percutaneous or surgical aortic valve repair is generally recommended as the primary management strategy in pediatric patients with aortic valve diseases [1, 3, 4]
The search for an ideal aortic valve substitute has been ongoing for more than fifty years [5], and multiple mature surgical options for aortic valve replacement (AVR) are available for patients, including Ross procedure, aortic homograft, mechanical prosthesis, and bio-prosthetic valves
Summary
Congenital birth defects such as aortic incompetence may lead to aortic failure. Nowadays, there have been a number of publications indicated the growing enthusiasm in the aortic valve repair techniques in children [1, 2]. Because of the encouraging mid- and long-term results in treating aortic stenosis or aortic regurgitation, percutaneous or surgical aortic valve repair is generally recommended as the primary management strategy in pediatric patients with aortic valve diseases [1, 3, 4]. Despite the fact that aortic valve repair has developed rapidly in pediatric patients, aortic valve replacement (AVR) may still be required in some cases, such as significant valve destruction and those after repair failure [4]. The search for an ideal aortic valve substitute has been ongoing for more than fifty years [5], and multiple mature surgical options for AVR are available for patients, including Ross procedure (pulmonary autograft), aortic homograft, mechanical prosthesis, and bio-prosthetic valves. The selection of a proper prosthesis for the pediatric patient can be challenging and controversial [1, 6], and each choice has its advantages and limitations
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have